Mona F Schaalan
Overview
Explore the profile of Mona F Schaalan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
448
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salama R, Yehia R, Elmongy N, Sallam A, Abd-Elgalil M, Schaalan M, et al.
Arch Pharm (Weinheim)
. 2024 Dec;
358(1):e2400641.
PMID: 39623809
Betanin (BET) has been studied for its therapeutic benefits in various diseases, but its low bioavailability and uncertain brain penetration limit its efficacy. Accordingly, this study aimed to explore BET-loaded...
2.
Salama R, Darwish S, Yehia R, Eissa N, Elmongy N, Abd-Elgalil M, et al.
Int Immunopharmacol
. 2024 Jun;
137:112536.
PMID: 38909495
Microglial activation contributes to the neuropathology of Parkinson's disease (PD). Inhibiting M1 while simultaneously boosting M2 microglia activation may therefore be a potential treatment for PD. Apilarnil (API) is a...
3.
Abdelwahab A, Negm A, Mahmoud E, Salama R, Schaalan M, El-Sheikh A, et al.
Front Pharmacol
. 2023 Jul;
14:1199294.
PMID: 37497114
Fast food is a major risk factor for atherosclerosis, a leading cause of morbidity and mortality in the Western world. Apelin, the endogenous adipokine, can protect against cardiovascular disease via...
4.
Sarhan R, Altyar A, Abou Warda A, Saied Y, Ibrahim H, Schaalan M, et al.
Pharmaceuticals (Basel)
. 2023 Apr;
16(4).
PMID: 37111389
COVID-19 is a fatal, fast-spreading pandemic, and numerous attempts are being made around the world to understand and manage the disease. COVID-19 patients may develop a cytokine-release syndrome, which causes...
5.
Sarhan N, Warda A, Sarhan R, Boshra M, Mostafa-Hedeab G, ALruwaili B, et al.
Medicina (Kaunas)
. 2022 Oct;
58(10).
PMID: 36295519
Vitamin D supplementation plays a key effect in lowering cytokine storms among COVID-19 patients by influencing the activity of the renin-angiotensin system and the production of the angiotensin-2 converting enzyme....
6.
El Gindy D, Solayman M, Khorshid R, Schaalan M, El Wakeel L
Cardiovasc Drugs Ther
. 2022 Sep;
38(1):99-108.
PMID: 36107363
Purpose: Prophylactic beta-blockers are recommended to prevent postoperative atrial fibrillation (POAF) after coronary artery bypass grafting (CABG). Polymorphisms in the beta-1 adrenergic receptor (ADRB1) and G protein-coupled receptor kinase 5...
7.
Abbas S, Schaalan M, Gebril S, Hassan F, Mahmoud M, Hassanin S
Life Sci
. 2022 Aug;
306:120850.
PMID: 35917938
Background: Cyclophosphamide (CP) is a widely used chemotherapeutic drug. However, the associated nephrotoxicity restricts its clinical use. Aim: The present research was designed to study the impact of LCZ696 (LCZ);...
8.
El Magdoub H, Schaalan M, Rahmo R, Farag D, Khedr L
Toxicol Appl Pharmacol
. 2020 Aug;
404:115184.
PMID: 32777238
Cisplatin (CIS)-mediated nephrotoxicity is induced via transforming growth factor-beta (TGF-β) and TGF-β-activated kinase (TAK1). TGF-β and TAK1 are known to interact with microRNA-let-7b and microRNA-26b, respectively. Additionally, TGF-β1 is reported...
9.
Abdel-Latif G, Elwahab A, Hasan R, Elmongy N, Ramzy M, L Louka M, et al.
Sci Rep
. 2020 Aug;
10(1):13045.
PMID: 32747644
Cyclophosphamide (CP) is a chemotherapeutic agent that induces oxidative stress causing multiple organ damage. Sacubitril/valsartan, is a combined formulation of neprilysin inhibitor (sacubitril) and angiotensin II receptor blocker (valsartan), that...
10.
Khedr L, Rahmo R, Farag D, Schaalan M, El Magdoub H
Food Chem Toxicol
. 2020 Apr;
140:111307.
PMID: 32259551
TLR4-induced mitigation of the BMP down-regulation and activin membrane bound inhibitor (BAMBI) and the consequent enhancement of the transforming growth factor-beta (TGF-β) profibrogenic signaling has not yet been studied in...